Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Dried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of Teriflunomide.
Phase 2 results of the RADIANCE trial: a randomized, double-blind, placebo-controlled trial of oral RPC1063 in relapsing multiple sclerosis
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis.
Review of MR elastography applications and recent developments.
Optic neuritis in a child with biotinidase deficiency: case report and literature review.
Autoinflammatory grey matter lesions in humans: cortical encephalitis, clinical disorders, experimental models.
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.
Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research.
Guillain-Barré syndrome in Colombia: where do we stand now?
Multiple sclerosis symptom recrudescence at the end of the natalizumab dosing cycle.
The site of production of superoxide radical in mitochondrial Complex I is not a bound ubisemiquinone but presumably iron-sulfur cluster N2.
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.
The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.
Does glatiramer acetate provoke hepatitis in multiple sclerosis?
Novartis gains FDA approval for Gilenya(TM), a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
European medicines agency's committee for medicinal products for human use issues positive opinion on marketing authorisation application for Fampyra
Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome.
Huperzine A ameliorates experimental autoimmune encephalomyelitis via the suppression of T cell-mediated neuronal inflammation in mice.
Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases
Emerging tumefactive MS after switching therapy from interferon-beta to fingolimod: A case report.
Epidural blood patch in a patient with multiple sclerosis: is it safe?
Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity.
Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial.
Biplanar MRI for the assessment of the spinal cord in multiple sclerosis.
[Pharmacological properties and clinical efficacy of fingolimod hydrochloride (Imusera®/Gilenya®) for the treatment of multiple sclerosis].

Pages